The WHO HPV LabNet has developed an international proficiency panel for HPV DNA detection and genotyping, and organized annual proficiency studies since 2008. It has been implemented study for HPV assays used in various laboratories, and in recent studies, total 119 laboratories participated in this study (2014 WHO HPV LabNet – Europe: 68 labs, Western
- info@buhlmannlabs.ch
- +41 61 487 12 12
News
We are pleased to announce the launch of the new BÜHLMANN GanglioCombi™ MAG ELISA. The assay is the only test in the field of Neuroimmunology for simultaneous detection of anti-MAG and anti-ganglioside antibodies. The most prominent gangliosides and MAG are aligned on a microtiter plate in order to define an autoimmune etiology of a peripheral neuropathy.
This year the United European Gastroenterology Week took place from October 24th to 28th in Barcelona. Over 13 000 participants from 114 countries were present. The BÜHLMANN team was among the 2325 exhibitors. This year’s UEGW marked an important event for us with the publication of the first clinical usability evaluation of IBDoc®. The data was
The BÜHLMANN fCAL turbo® is now available. The first immunoturbidimetric assay is applicable on all major chemistry analyzers and offers reliable and fast results in the determination of fecal calprotectin. The broad calibration range from 20-2000 µg/g calprotectin reduces the amount of retesting down to <4%, whereby the measuring range is from 20-8000 µg/g calprotectin. Furthermore, since the
Social Links